Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NeoOncoRx to acquire worldwide rights to novel class of anticancer agents

Jan. 5, 2001

NCI compounds targeting tumors in the brain licensed by Ivax

Jan. 5, 2001

Clinical trials expected to begin for ILX-651 this quarter

Jan. 4, 2001

NCI funds development of novel vector that enhances tumor cell radiosensitivity

Jan. 3, 2001

Preclinical studies on interaction of STI-571 with chemotherapeutic agents and radiation

Jan. 3, 2001

BLA for Zevalin granted priority review by FDA

Jan. 3, 2001

Genta licenses technology platform for designing novel anticancer treatments

Jan. 3, 2001

Bioniche bladder cancer trial yields positive interim results

Jan. 3, 2001

Enhanced version of MetXia to be codeveloped by Oxford BioMedica and PolyMASC

Jan. 3, 2001

Clinical trial commences for new antiangiogenic agent discovered by OSI and Pfizer

Jan. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...